Jazz Pharmaceuticals plc (JAZZ) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Jazz Pharmaceuticals plc (JAZZ) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $14.58B, listed on NASDAQ, employing roughly 2,800 people, carrying a beta of 0.27 to the broader market. Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Led by Renee D. Gala, public since 2007-06-01.
Snapshot as of May 15, 2026.
- Spot Price
- $228.38
- Total OI
- 10.7K